Advertisement

Picture [iito] Back into Ad 650x80px

News > Benelux countries

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 1718 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK in Advanced Discussions with European Union to Supply up to 300 Million Doses of COVID-19 Vaccine". London & Paris. 2020-07-31
GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 vaccine". London & Paris. 2020-07-31
Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden. 2020-07-29
ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven. 2020-07-28
Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. 2020-07-28
iTeos Therapeutics Inc.. (7/23/20). "Press Release: iTeos Therapeutics Announces Pricing of Initial Public Offering". Cambridge, MA & Gosselies. 2020-07-23
Citryll B.V.. (7/21/20). "Press Release: Industry Veterans Paul Peter Tak and Eric Meldrum Join Citryll’s Board". Oss. 2020-07-21
Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. 2020-07-16
Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam. 2020-07-13
Belgian Growth Fund. (7/9/20). "Press Release: Final Closing Belgian Growth Fund at 312 Million Euro". 2020-07-09
Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. 2020-07-09
VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. 2020-07-08
Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. 2020-07-08
Citryll B.V.. (7/2/20). "Press Release: Citryll Completes € 18.5 M Fundraise to Develop CIT-013, an Antibody Targeting Neutrophil Extracellular Traps". Oss. 2020-07-02
Immatics N.V.. (7/2/20). "Press Release: Immatics Announces Completion of Business Combination and Listing on NASDAQ". Houston, TX & Tübingen. 2020-07-02
S-Biomedic N.V.. (7/2/20). "Press Release: S-Biomedic Is Gearing Up for Significant Growth and Has Appointed a New CCO". Beerse. 2020-07-02
Cergentis B.V.. (6/29/20). "Press Release: Cergentis Appoints New CEO and Board Members". Utrecht. 2020-06-29
PDC*line Pharma S.A.. (6/25/20). "Press Release: PDC*line Pharma Welcomes Dr. Mondher Mahjoubi as Chairman of Its Board of Directors". Liège & Grenoble. 2020-06-25
BioGeneration Ventures B.V.. (6/24/20). "Press Release: BioGeneration Ventures Closes BGV IV Fund at €105 Million". Naarden. 2020-06-24
Uniqure N.V.. (6/24/20). "Press Release: Uniqure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy". Lexington, MA & Amsterdam. 2020-06-24
Qiagen N.V.. (6/23/20). "Press Release: Qiagen Provides Information on Potential Capital Gain from Its Minority Investment in ArcherDX". Venlo. 2020-06-23
Scenic Biotech B.V.. (6/23/20). "Press Release: Scenic Biotech Awarded €3.1 Million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program". Amsterdam. 2020-06-23
Uniqure N.V.. (6/17/20). "Press Release: Uniqure Announces the Appointment of Leonard E. Post, Ph.D. to Its Board of Directors". Lexington, MA & Amsterdam. 2020-06-17
Hyloris Pharmaceuticals S.A.. (6/17/20). "Press Release: Hyloris Pharmaceuticals Launches Its Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège. 2020-06-17
eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel. 2020-06-16
Bioqube Ventures. (6/10/20). "Press Release: Bioqube Ventures Launches Bioqube Factory Fund I". Hasselt/Brussels. 2020-06-10
iTeos Therapeutics Inc.. (6/9/20). "Press Release: iTeos Therapeutics Strengthens Leadership Team. Matthew Gall Joins as Chief Financial Officer". Cambridge, MA & Gosselies. 2020-06-09
Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège. 2020-06-03
Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya. 2020-06-03
Argenx SE. (5/29/20). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. 2020-05-29
Argenx SE. (5/28/20). "Press Release: Argenx Raises $750 Million in Gross Proceeds in a Global Offering". Breda & Ghent. 2020-05-28
Argenx SE. (5/26/20). "Press Release: Argenx Announces Positive Topline Phase 3 ADAPT Trial Results". Breda & Ghent. 2020-05-26
Argenx SE. (5/26/20). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. 2020-05-26
Oxford Nanopore Technologies Ltd.. (5/26/20). "Press Release: Oxford Nanopore Announces £48.4M ($59.2M) in New Capital to Support Ongoing Innovation and the Rapid Worldwide Growth of Nanopore Sequencing". Oxford. 2020-05-26
Hyloris Pharmaceuticals S.A.. (5/26/20). "Press Release: Hyloris Appoints Patrick Jeanmart as Chief Financial Officer". Liège. 2020-05-26
Syngulon S.A.. (5/16/20). "Press Release: Enzymicals and Syngulon Sign a Non-exclusive License Agreement on the Use of Syngulon’s Antibiotic Free Technology to Produce Enzymes". Seraing. 2020-05-16
Lava Therapeutics B.V.. (5/15/20). "Press Release: Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics". Utrecht. 2020-05-15
Polyganics B.V.. (5/13/20). "Press Release: Polyganics Awarded €1.2 Million for Clinical Development of Liver and Pancreas Sealant Patch". Groningen. 2020-05-13
Hyloris Pharmaceuticals S.A.. (4/30/20). "Press Release: Hyloris Pharmaceuticals Successfully Raises €15 Million in Funding Round". Liège. 2020-04-30
Bone Therapeutics S.A.. (4/29/20). "Press Release: Bone Therapeutics Secures EUR 11.0 Million Financing". Gosselies. 2020-04-29
Centogene B.V.. (4/17/20). "Press Release: Centogene and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19". Rostock & Cologne. 2020-04-17
Galapagos N.V.. (4/16/20). "Press Release: Galapagos and Ryvu Announce Research Collaboration". Mechelen & Krakow. 2020-04-16
Halix B.V.. (4/15/20). "Press Release: Halix Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine". Leiden. 2020-04-15
GlaxoSmithKline plc. (4/14/20). "Press Release: Sanofi and GSK to Join Forces in Unprecedented Vaccine Collaboration to Fight COVID-19". London. 2020-04-14
Gadeta B.V.. (4/7/20). "Press Release: Gadeta Appoints Marco Londei as Chief Executive Officer". Utrecht. 2020-04-07
iTeos Therapeutics Inc.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. 2020-04-01
AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht. 2020-03-31
Qiagen N.V.. (3/31/20). "Press Release: Qiagen Receives U.S. FDA EUA for QIAstat-Dx Test Kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus". Germantown, MD & Hilden. 2020-03-31
Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. 2020-03-31
InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. 2020-03-31
Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. 2020-03-26
Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. 2020-03-24
Virometix AG. (3/12/20). "Press Release: Virometix Announces Initiation of Phase 1 Clinical Trial with Its V-306 Vaccine Candidate". Schlieren. 2020-03-12
Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. 2020-03-10
UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. 2020-03-09
Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. 2020-03-05
Biotalys N.V.. (3/5/20). "Press Release: Biotalys Announces Second Closing of €45 Million Series C Financing Round". Ghent. 2020-03-05
Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen. 2020-03-05
Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen. 2020-03-05
Qiagen N.V.. (3/3/20). "Press Release: Conclusion of a Business Combination Agreement between Qiagen N.V. and Thermo Fisher Scientific Inc., Announcement of a Public Tender Offer by Thermo Fisher Scientific Inc. [Ad hoc]". Venlo. 2020-03-03
Qiagen N.V.. (3/3/20). "Press Release: Thermo Fisher Scientific to Acquire Qiagen N.V.". Waltham, MA & Venlo. 2020-03-03
Uniqure N.V.. (3/2/20). "Press Release: Uniqure Announces 2019 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2020-03-02
PDC*line Pharma S.A.. (3/2/20). "Press Release: PDC*line Pharma Announces the Administration of a First Patient with Its Therapeutic Cancer Vaccine Candidate (PDC*lung01) Targeting Non-small Cell Lung Cancer". Liège & Grenoble. 2020-03-02
Uniqure N.V.. (3/2/20). "Press Release: Uniqure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters". Lexington, MA & Amsterdam. 2020-03-02
iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies. 2020-02-27
DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. 2020-02-21
Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. 2020-02-18
OncoDNA S.A.. (2/14/20). "Press Release: OncoDNA Closes Successful Series B Investment Round". Gosselies. 2020-02-14
Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. 2020-02-06
iTeos Therapeutics S.A.. (1/30/20). "Press Release: iTeos Therapeutics Awarded €15 Million in Non-Dilutive Funding by the Walloon Region". Gosselies & Cambridge, MA. 2020-01-30
Biocartis Group N.V.. (1/27/20). "Press Release: Biocartis Announces Resignation of CFO". Mechelen. 2020-01-27
iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. 2020-01-23
Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. 2020-01-23
PDC*line Pharma S.A.. (1/22/20). "Press Release: PDC*line Pharma Raises €20 million in Series B Financing Round". Liège & Grenoble. 2020-01-22
Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto. 2020-01-15
Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. 2020-01-14
Galapagos N.V.. (1/13/20). "Press Release: Galapagos Completes Recruitment of PINTA Trial in Idiopathic Pulmonary Fibrosis". Mechelen. 2020-01-13
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. 2020-01-08
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. 2019-12-19
Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium. 2019-12-16
Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe 2019-12-16
iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. 2019-12-12
Biotalys N.V.. (12/10/19). "Press Release: AgroSavfe Announces Name Change to Biotalys and Incorporation of US Subsidiary, Biotalys, Inc.". Ghent. 2019-12-10
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". 2019-11-29
Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. 2019-11-28
Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. 2019-11-27
Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". 2019-11-20
Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. 2019-11-20
Qiagen N.V.. (11/15/19). "Press Release: Qiagen Receives Several Conditional, Non-binding Indications of Interest, Enters into Discussions to Explore Potential Strategic Alternatives". Venlo. 2019-11-15
Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam. 2019-11-12
Argenx SE. (11/8/19). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. 2019-11-08
Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. 2019-11-07
Argenx SE. (11/7/19). "Press Release: Argenx Raises $484 Million in Gross Proceeds in a Global Offering". Breda & Ghent. 2019-11-07
Argenx SE. (11/6/19). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. 2019-11-06
Cato Research, LLC. (10/28/19). "Press Release: Cato Research Announces Merger with SMS-Oncology". Durham, NC. 2019-10-28
Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. 2019-10-28
Uniqure N.V.. (10/28/19). "Press Release: Uniqure Announces Third Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2019-10-28
Galapagos N.V.. (10/25/19). "Press Release: Galapagos Receives Transparency Notification from Wellington Management Group LLP". Mechelen. 2019-10-25
Galapagos N.V.. (10/24/19). "Press Release: Solid Third Quarter 2019 Performance with Strong Balance Sheet for Continued R&D Growth". Mechelen. 2019-10-24
Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. 2019-10-22
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page



Advertisement

Picture [iito] No Tracking 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top